Literature DB >> 4126632

Letter: Treatment of aphthous stomatitis.

H Verhaegen, J De Cree, J Brugmans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126632     DOI: 10.1016/s0140-6736(73)90879-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

2.  Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole.

Authors:  J Symoens; J Brugmans
Journal:  Br Med J       Date:  1974-12-07

Review 3.  Use of levamisole in recurrent aphthous stomatitis.

Authors:  M F Miller
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

4.  In vitro stimulation of murine lymphoid cell cultures by levamisole.

Authors:  V J Merluzzi; A M Badger; C W Kaiser; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

5.  L-tetramisole. Enhancement of human lymphocyte response to antigen.

Authors:  H F Pabst; J Crawford
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

6.  Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.

Authors:  W De Cock; J De Cree; H Verhaegen
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

7.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

8.  Levamisole in aphthous stomatitis: evaluation of three regimens.

Authors:  J D Meyer; M Degraeve; J Clarysse; F De Loose; W Peremans
Journal:  Br Med J       Date:  1977-03-12

9.  Levamisole treatment of a child with severe aphthous stomatitis and neutropenia.

Authors:  H Verhaegen; J De Crée; W De Cock; J Brugmans
Journal:  Postgrad Med J       Date:  1976-08       Impact factor: 2.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.